CytoMed Therapeutics Ltd

GDTC

Company Profile

  • Business description

    CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

  • Contact

    1 Commonwealth Lane
    No. 08-22 One Commonwealth
    Singapore149544
    SGP

    T: +65 62507738

    https://w2.cytomed.sg

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    42

Stocks News & Analysis

stocks

Why great earnings haven't been good enough for AI hardware stocks

Stocks that had been posting triple-digit returns are sliding on earnings results.
stocks

Fair Value increased for Big 4 bank after earnings

Shares still overvalued, with analysts thinking the fundamentals no longer matter to the share price.
stocks

Chart of the Week: Why ASX tech is poised for a comeback

The “SaaSpocalypse” never arrived. Now, software stocks are positioning for a long-awaited comeback.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,381.409.10-0.10%
CAC 408,691.9517.010.20%
DAX 4026,467.79136.720.52%
Dow JONES (US)53,770.2721.58-0.04%
FTSE 10010,809.6423.51-0.22%
HKSE25,396.5143.66-0.17%
NASDAQ26,588.49143.040.54%
Nikkei 22568,308.59784.531.16%
NZX 50 Index13,825.3087.640.64%
S&P 5007,748.5020.300.26%
S&P/ASX 2009,188.504.40-0.05%
SSE Composite Index3,926.9619.71-0.50%

Market Movers